248 related articles for article (PubMed ID: 27363398)
1. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
Okada Y; Murata M; Toda T
Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
[TBL] [Abstract][Full Text] [Related]
2. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
3. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.
Skodda S; Visser W; Schlegel U
J Neural Transm (Vienna); 2010 Feb; 117(2):197-205. PubMed ID: 20012657
[TBL] [Abstract][Full Text] [Related]
5. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
Whitfield JA; Goberman AM
J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
[TBL] [Abstract][Full Text] [Related]
6. Impairment of vowel articulation as a possible marker of disease progression in Parkinson's disease.
Skodda S; Grönheit W; Schlegel U
PLoS One; 2012; 7(2):e32132. PubMed ID: 22389682
[TBL] [Abstract][Full Text] [Related]
7. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
[TBL] [Abstract][Full Text] [Related]
8. Vowel articulation in Parkinson's disease.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Jul; 25(4):467-72. PubMed ID: 20434876
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
[TBL] [Abstract][Full Text] [Related]
10. Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
Gentil M; Tournier CL; Pollak P; Benabid AL
Eur Neurol; 1999; 42(3):136-40. PubMed ID: 10529538
[TBL] [Abstract][Full Text] [Related]
11. Automated Vowel Articulation Analysis in Connected Speech Among Progressive Neurological Diseases, Dysarthria Types, and Dysarthria Severities.
Illner V; Tykalova T; Skrabal D; Klempir J; Rusz J
J Speech Lang Hear Res; 2023 Aug; 66(8):2600-2621. PubMed ID: 37499137
[TBL] [Abstract][Full Text] [Related]
12. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
[TBL] [Abstract][Full Text] [Related]
13. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.
De Letter M; Van Borsel J; Boon P; De Bodt M; Dhooge I; Santens P
Int J Speech Lang Pathol; 2010 Oct; 12(5):405-13. PubMed ID: 20602581
[TBL] [Abstract][Full Text] [Related]
15. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
16. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
[TBL] [Abstract][Full Text] [Related]
18. Glottographic measures before and after levodopa treatment in Parkinson's disease.
Jiang J; Lin E; Wang J; Hanson DG
Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
[TBL] [Abstract][Full Text] [Related]
19. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
20. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
